Advertisement

Topics

Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment

15:26 EST 19 Jan 2019 | PharmaBiz

Therachon AG, a clinical─stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for serious rare conditions, announced that the US Food and Drug

Original Article: Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment

NEXT ARTICLE

More From BioPortfolio on "Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...